Back
Pediatrix Medical Group Quote, Financials, Valuation and Earnings
Sell
36
MD
Pediatrix Medical Group
Last Price:
7.79
Seasonality Move:
3.77%
7 Day Trial
ALL ACCESS PASS
$
7
Pediatrix Medical Group Price Quote
$7.79
Pediatrix Medical Group Key Stats
Sell
36
Pediatrix Medical Group (MD)
is a Sell
Day range:
$7.77 - $8.19
52-week range:
$7.70 - $15.02
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.32
P/B ratio:
0.77%
Volume:
1M
Avg. volume:
699.2K
1-year change:
-43.43%
Market cap:
$655.5M
Revenue:
$2B
EPS:
$-0.85
How Much Does Pediatrix Medical Group Make?
-
How Much Are Pediatrix Medical Group's Sales Annually?
MD Revenues are $2B -
How Much Profit Does Pediatrix Medical Group's Make A Year?
MD net income is -$60.4M
Is Pediatrix Medical Group Growing As A Company?
-
What Is Pediatrix Medical Group's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.01% -
What Is Pediatrix Medical Group's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.71%
Pediatrix Medical Group Stock Price Performance
-
Did Pediatrix Medical Group Stock Go Up Last Month?
Pediatrix Medical Group share price went down by -12.67% last month -
Did MD's Share Price Rise Over The Last Year?
MD share price fell by -43.43% over the past 1 year
What Is Pediatrix Medical Group 52-Week High & Low?
-
What Is Pediatrix Medical Group’s 52-Week High Share Price?
Pediatrix Medical Group has traded as high as $15.02 over the past 52 weeks -
What Is Pediatrix Medical Group’s 52-Week Low Share Price?
Pediatrix Medical Group has traded as low as $7.70 over the past 52 weeks
Pediatrix Medical Group Price To Free Cash Flow
-
Is Pediatrix Medical Group Stock Overvalued?
Pediatrix Medical Group is trading at a price to free cash flow ratio of 7.93 -
Is Pediatrix Medical Group Stock Undervalued?
Pediatrix Medical Group EV to Free Cash Flow ratio is 15.36 -
What Is Pediatrix Medical Group’s Price Earnings Growth Ratio?
MD PEG ratio is 0.00 -
Is Pediatrix Medical Group Trading At A Premium To Earnings?
Pediatrix Medical Group EV to EBIT ratio is 0.00
Is It Risky To Buy Pediatrix Medical Group?
-
How Much Debt Does Pediatrix Medical Group Have?
Total long term debt quarterly is $709.8M -
How Much Cash Does Pediatrix Medical Group Have?
Cash and short term investments quarterly total is $115.5M -
What Is Pediatrix Medical Group’s Book Value Per Share?
Book value per share is 10.19
Is Pediatrix Medical Group Cash Flow Positive?
-
What Is MD Cash Flow From Operations?
Cash flow from operations (TTM) is $113M -
What Is Pediatrix Medical Group’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$58.1M -
What Is Pediatrix Medical Group’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$53.1M
Pediatrix Medical Group Return On Invested Capital
-
Is Management Doing A Good Job?
MD return on invested capital is -4.45% -
What Is Pediatrix Medical Group Return On Assets?
ROA measures how assets are converting to revenues and is -3.11% -
What Is MD Return On Equity?
ROE is a measure of profitability and is -7.8%
Pediatrix Medical Group Earnings Date & Stock Price
-
What Is Pediatrix Medical Group's Stock Price Today?
A single share of MD can be purchased today for 7.79 -
What Is Pediatrix Medical Group’s Stock Symbol?
Pediatrix Medical Group trades on the nyse under the ticker symbol: MD -
When Is Pediatrix Medical Group’s Next Earnings Date?
The next quarterly earnings date for Pediatrix Medical Group is scheduled on August 2, 2024 -
When Is MD's next ex-dividend date?
Pediatrix Medical Group's next ex-dividend date is May 17, 2024 -
How To Buy Pediatrix Medical Group Stock?
You can buy Pediatrix Medical Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Pediatrix Medical Group Competitors
-
Who Are Pediatrix Medical Group's Competitors?
Below is a list of companies who compete with Pediatrix Medical Group or are related in some way:
Pediatrix Medical Group Dividend Yield
Data Unavailable
Pediatrix Medical Group Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -70.59% | 5.9% |
| Revenue: | 0.83% | -1.06% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 1 |
| Price Target: | 9.00 |
| Upside from Last Price: | 15.53% |